AQR Capital Management - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 71 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is 42.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2015$840,000
+27.5%
161,537
+48.2%
0.00%0.0%
Q3 2015$659,000
-17.2%
109,033
+116.2%
0.00%
-50.0%
Q2 2015$796,000
+512.3%
50,432
+271.1%
0.00%
Q3 2014$130,000
-77.6%
13,591
-72.9%
0.00%
-100.0%
Q2 2014$580,000
-30.9%
50,191
-40.2%
0.00%
-33.3%
Q1 2014$839,000
+19.9%
83,891
+56.0%
0.00%
+50.0%
Q4 2013$700,000
-68.9%
53,791
-64.3%
0.00%
-75.0%
Q3 2013$2,250,000150,5800.01%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders